Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zwi N Berneman

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Journal of Leukocyte Biology|August 23, 2007
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cellsNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
The Oncologist|March 18, 2009
Immunotherapy of acute myeloid leukemia: current approachesEvelien L J M Smits, Zwi N Berneman, Viggo F I Van Tendeloo
Cancers|February 5, 2020
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?Yannick Willemen, Maarten Versteven, Marc Peeters, et al.
Human Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.
Platelets|May 25, 2004
Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia veraJan Jacques Michiels, Zwi N Berneman, Wilfried Schroyens, et al.
The Lancet. Oncology|May 30, 2014
Clinical use of dendritic cells for cancer therapySébastien Anguille, Evelien L Smits, Eva Lion, et al.
Bulletin Du Cancer|April 9, 2008
Immunotherapy of hematological malignancies using dendritic cellsAnn L R Van de Velde, Zwi N Berneman, Viggo F I Van Tendeloo
The Oncologist|August 22, 2012
NK cells: key to success of DC-based cancer vaccines?Eva Lion, Evelien L J M Smits, Zwi N Berneman, et al.
Leukemia Research|October 11, 2008
Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cellsEva Lion, Evelien L J M Smits, Zwi N Berneman, et al.
The Oncologist|August 15, 2008
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapyEvelien L J M Smits, Peter Ponsaerts, Zwi N Berneman, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Journal of Leukocyte Biology|August 23, 2007
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cellsNathalie Cools, Peter Ponsaerts, Viggo F I Van Tendeloo, et al.
The Oncologist|March 18, 2009
Immunotherapy of acute myeloid leukemia: current approachesEvelien L J M Smits, Zwi N Berneman, Viggo F I Van Tendeloo
Cancers|February 5, 2020
Ribonucleic Acid Engineering of Dendritic Cells for Therapeutic Vaccination: Ready 'N Able to Improve Clinical Outcome?Yannick Willemen, Maarten Versteven, Marc Peeters, et al.
Human Vaccines|March 23, 2011
Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answersSébastien Anguille, Eva Lion, Evelien Smits, et al.
Platelets|May 25, 2004
Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia veraJan Jacques Michiels, Zwi N Berneman, Wilfried Schroyens, et al.
The Lancet. Oncology|May 30, 2014
Clinical use of dendritic cells for cancer therapySébastien Anguille, Evelien L Smits, Eva Lion, et al.
Bulletin Du Cancer|April 9, 2008
Immunotherapy of hematological malignancies using dendritic cellsAnn L R Van de Velde, Zwi N Berneman, Viggo F I Van Tendeloo
The Oncologist|August 22, 2012
NK cells: key to success of DC-based cancer vaccines?Eva Lion, Evelien L J M Smits, Zwi N Berneman, et al.
Leukemia Research|October 11, 2008
Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cellsEva Lion, Evelien L J M Smits, Zwi N Berneman, et al.
The Oncologist|August 15, 2008
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapyEvelien L J M Smits, Peter Ponsaerts, Zwi N Berneman, et al.
Pageof 12